I-Mab Biopharma
About:
I-Mab is a dynamic and fast-growing global biotech company exclusively focused on developing innovative biologics.
Website: http://www.i-mabbiopharma.com/
Top Investors: OrbiMed, Perceptive Advisors, Cormorant Asset Management, Invus, EDBI
Description:
I-MAB is a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. .
Total Funding Amount:
$815M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Shanghai, Shanghai, China
Founded Date:
2016-01-01
Contact Email:
marcom(AT)i-mabbiopharma.com
Founders:
Jingwu Zang
Number of Employees:
251-500
Last Funding Date:
2020-09-04
IPO Status:
Public
© 2025 bioDAO.ai